Who makes Hidrocortisone?

Hidrocortisone is developed by PETHEMA Foundation.

What development phase is Hidrocortisone in?

Hidrocortisone is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Hidrocortisone

PETHEMA Foundation · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Hidrocortisone
Sponsor	PETHEMA Foundation
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Hidrocortisone CI brief — competitive landscape report
Hidrocortisone updates RSS · CI watch RSS
PETHEMA Foundation portfolio CI